# Vaccine Policy in India

**Authors:** Yennapu Madhavi

PMC · DOI: 10.1371/journal.pmed.0020127 · 2005-05-31

## TL;DR

India initially succeeded in vaccine development and production but now struggles with a growing gap between vaccine demand and supply.

## Contribution

Highlights the shift from early vaccine self-sufficiency to current supply-demand challenges in India.

## Key findings

- India had early success in indigenous vaccine development and production.
- A growing gap exists between the demand for and supply of essential vaccines in the country.

## Abstract

India enjoyed early initial successes in vaccine development and indigenous production of vaccines in the public sector. But the country now faces a growing gap between the demand for and supply of essential vaccines.

## Full-text entities

- **Diseases:** chickenpox (MESH:D002644), typhoid (MESH:D014435), Viral Encephalitis (MESH:D018792), Hepatitis B (MESH:D006509), measles (MESH:D008457), SII (MESH:D054000), IPV (MESH:D011051), Plague (MESH:D010930), tropical diseases (MESH:D015493), measles-mumps-rubella (MESH:D009107), diphtheria (MESH:D004165), cholera (MESH:D002771), UIP (MESH:C563594), DPT (MESH:D013746), influenza type B (MESH:D008583), meningitis (MESH:D008580)
- **Chemicals:** DPT (-),  (MESH:D014612)
- **Species:** Homo sapiens (human, species) [taxon 9606], Panacea (genus) [taxon 127360]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC1140944/full.md

---
Source: https://tomesphere.com/paper/PMC1140944